B P Alter. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Administration, OralAgranulocytosis/chemically inducedAnemia/drug therapyDeferiproneHumansIron Chelating Agents/adverse effectsLeukocyte CountPyridones/adverse effectsSyndromeThrombocytopenia/chemically induced
Substances： See more » Iron Chelating AgentsPyridonesDeferiprone
Year: 1990 PMID： 1970037 DOI： 10.1016/0140-6736(90)91031-5
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321